9 -Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB 1 receptors

By Krowicki Z.K.   Moerschbaecher J.M.   Winsauer P.J.   Digavalli S.V.   Hornby P.J.  

European Journal of Pharmacology, Vol. 371, Iss. 2, 1999-04 ,pp. : 187-196

Elsevier

Access to resources Recommend Favorite

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB 1 /CB 2 receptors

By Brooks J.W.   Pryce G.   Bisogno T.   Jaggar S.I.   Hankey D.J.R.   Brown P.   Bridges D.   Ledent C.   Bifulco M.   Rice A.S.C.   Di Marzo V.   Baker D.  

European Journal of Pharmacology, Vol. 439, Iss. 1, 2002-03 ,pp. : 83-92

Elsevier

Access to resources Recommend Favorite

Potentiation of 9 -tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of - and -opioid receptors

By Reche I.   Fuentes J.A.   Ruiz-Gayo M.  

European Journal of Pharmacology, Vol. 318, Iss. 1, 1996-12 ,pp. : 11-16

Elsevier

Access to resources Recommend Favorite

Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects of the cannabinoid CB₁ antagonist SR 141716A in rhesus monkeys pretreated with ∆⁹-tetrahydrocannabinol

By McMahon Lance  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 306-314

Springer Publishing Company

Access to resources Recommend Favorite